Literature DB >> 21419454

Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study.

Andrea Minervini1, Vincenzo Ficarra, Francesco Rocco, Alessandro Antonelli, Roberto Bertini, Giorgio Carmignani, Sergio Cosciani Cunico, Dario Fontana, Nicola Longo, Giuseppe Martorana, Vincenzo Mirone, Giuseppe Morgia, Giacomo Novara, Marco Roscigno, Riccardo Schiavina, Sergio Serni, Claudio Simeone, Alchiede Simonato, Salvatore Siracusano, Alessandro Volpe, Filiberto Zattoni, Alessandro Zucchi, Marco Carini.   

Abstract

PURPOSE: The excision of the renal tumor with a substantial margin of healthy parenchyma is considered the gold standard technique for partial nephrectomy. However, simple enucleation showed excellent results in some retrospective series. We compared the oncologic outcomes after standard partial nephrectomy and simple enucleation.
MATERIALS AND METHODS: We retrospectively analyzed 982 patients who underwent standard partial nephrectomy and 537 who had simple enucleation for localized renal cell carcinoma at 16 academic centers between 1997 and 2007. Local recurrence, cancer specific survival and progression-free survival were the main outcomes of this study. The Kaplan-Meier method was used to calculate survival functions and differences were assessed with the log rank statistic. Univariable and multivariable Cox regression models addressed progression-free survival and cancer specific survival.
RESULTS: Median followup of the patients undergoing traditional partial nephrectomy and simple enucleation was 51 ± 37.8 and 54.4 ± 36 months, respectively (p = 0.08). The 5 and 10-year progression-free survival estimates were 88.9 and 82% after standard partial nephrectomy, and 91.4% and 90.8% after simple enucleation (p = 0.09). The 5 and 10-year cancer specific survival estimates were 93.9% and 91.6% after standard partial nephrectomy, and 94.3% and 93.2% after simple enucleation (p = 0.94). On multivariable analysis the adopted nephron sparing surgery technique was not an independent predictor of progression-free survival (HR 0.8, p = 0.55) and cancer specific survival (HR 0.7, p = 0.53) when adjusted for the effect of the other covariates.
CONCLUSIONS: To our knowledge this is the first multicenter, comparative study showing oncologic equivalence of standard partial nephrectomy and simple enucleation.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21419454     DOI: 10.1016/j.juro.2010.12.048

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

1.  Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results.

Authors:  Andrea Minervini; Agostino Tuccio; Lorenzo Masieri; Domenico Veneziano; Gianni Vittori; Giampaolo Siena; Mauro Gacci; Graziano Vignolini; Andrea Mari; Arcangelo Sebastianelli; Matteo Salvi; Sergio Serni; Marco Carini
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

Review 2.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

Review 3.  Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.

Authors:  Dean D Laganosky; Christopher P Filson; Viraj A Master
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

4.  Modified laparoscopic simple enucleation with single-layer suture technique versus standard laparoscopic partial nephrectomy for treating localized renal cell carcinoma.

Authors:  Qun Lu; Xiaozhi Zhao; Changwei Ji; Suhan Guo; Guangxiang Liu; Shiwei Zhang; Xiaogong Li; Weidong Gan; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2016-11-28       Impact factor: 2.370

5.  Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project).

Authors:  Andrea Minervini; Giampaolo Siena; Alessandro Antonelli; Giampaolo Bianchi; Aldo Massimo Bocciardi; Sergio Cosciani Cunico; Vincenzo Ficarra; Cristian Fiori; Ferdinando Fusco; Andrea Mari; Giuseppe Martorana; Mauro Medica; Vincenzo Mirone; Giuseppe Morgia; Francesco Porpiglia; Francesco Rocco; Bruno Rovereto; Riccardo Schiavina; Claudio Simeone; Carlo Terrone; Alessandro Volpe; Marco Carini; Sergio Serni
Journal:  World J Urol       Date:  2013-09-07       Impact factor: 4.226

6.  Perioperative and renal functional outcomes of laparoscopic partial nephrectomy (LPN) for renal tumours of high surgical complexity: a single-institute comparison between clampless and clamped procedures.

Authors:  Paolo Verze; Paolo Fedelini; Francesco Chiancone; Vito Cucchiara; Roberto La Rocca; Maurizio Fedelini; Clemente Meccariello; Alessandro Palmieri; Vincenzo Mirone
Journal:  World J Urol       Date:  2016-06-20       Impact factor: 4.226

7.  Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors.

Authors:  Rocco Papalia; Valeria Panebianco; Riccardo Mastroianni; Maurizio Del Monte; Emanuela Altobelli; Eliodoro Faiella; Francesco Rosario Grasso; Mariangela Bellangino; Giuseppe Simone; Massimo Ciccozzi; Silvia Angeletti; Giulia D'ovidio; Carlo Catalano; Michele Gallucci; Roberto Mario Scarpa; Giovanni Muto
Journal:  World J Urol       Date:  2019-04-25       Impact factor: 4.226

8.  Renal function after kidney surgery: "it's tough to make predictions, especially about the future".

Authors:  John M DiBianco; Patrick T Gomella; Mark W Ball
Journal:  Ann Transl Med       Date:  2019-07

9.  Tumor Enucleation of Renal Cell Carcinoma in a Solitary Kidney.

Authors:  N J Farber; I Faiena; J S Parihar; E A Singer
Journal:  Austin J Surg       Date:  2015

Review 10.  Partial nephrectomy--contemporary indications, techniques and outcomes.

Authors:  Scott Leslie; Alvin C Goh; Inderbir S Gill
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.